Literature DB >> 20615755

Breast cancer diagnosis following ovarian stimulation: are the tumours different?

Murat Sönmezer1, Aylin Pelin Cil, Ozgur Oktem, Kutluk Oktay.   

Abstract

Demographic data and tumour characteristics of 18 patients (study group) diagnosed with breast cancer within 24 months of undergoing ovarian stimulation with either gonadotrophins or clomiphene citrate were evaluated and compared with similar 102 age-matched women diagnosed with breast cancer without prior infertility treatment (control group). Eight out of 17 (47.1%) patients in the study group and 35/95 (36.8%) patients in the control group had positive family history for breast cancer. Median tumour size was similar in the study and control groups (both 1.3 cm). Both groups were comparable regarding tumour histological types and oestrogen receptor, progesterone receptor and Her2/Neu expression status. Albeit not significant, stage 0 tumours were more prevalent in the study group compared with the control group (22.2% versus 10.5%), and there were no stage III tumours in the study group as opposed to 7/95 in the control group. In conclusion, breast cancer diagnosed within the first 2 years following infertility treatment is similar in tumour characteristics compared with those occurring in patients without prior infertility treatment. 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615755     DOI: 10.1016/j.rbmo.2010.05.006

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

Review 1.  Safety of clomiphene citrate: a literature review.

Authors:  Serkan Yilmaz; Neslihan Yilmaz Sezer; İlknur Münevver Gönenç; Sibel Erkal İlhan; Ebru Yilmaz
Journal:  Cytotechnology       Date:  2017-11-20       Impact factor: 2.058

2.  Ovarian stimulation in patients with breast cancer.

Authors:  Elkin Muñoz; Naira González; Luis Muñoz; Jesús Aguilar; Juan A García Velasco
Journal:  Ecancermedicalscience       Date:  2015-02-03

Review 3.  Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.

Authors:  Zohre Momenimovahed; Safoura Taheri; Azita Tiznobaik; Hamid Salehiniya
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.